Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67 participants
OBSERVATIONAL
2004-11-30
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Aortic aneurysm repair
No interventions assigned to this group
2
Aortic aneurysm growth
No interventions assigned to this group
3
Aortic aneurysm growth stable.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI 31 or less.
* Creatinine results \<2.0 and within six months prior to scan.
* US patients must have only normal creatinine (0.9 to 1.4) for one year before study visit.
* Patients who are originally scheduled for US, who are then subsequently rolled in this study, will have only a ultrasound scan as followup after the initial CTA.
Exclusion Criteria
* Creatinine \<0.9 or \>1.4 for those who are scheduled for US.
* Atrial fibrillation or other arrythmia.
* Known AAA greater than 5 cm in size.
* Allergy to contrast dye.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Flight Attendant Medical Research Institute
OTHER
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mayo Clinic Rochester, Minnesota
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joel G. Fletcher, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic - Rochester, Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zhang J, Fletcher JG, Vrtiska TJ, Manduca A, Thompson JL, Raghavan ML, Wentz RJ, McCollough CH. Large-vessel distensibility measurement with electrocardiographically gated multidetector CT: phantom study and initial experience. Radiology. 2007 Oct;245(1):258-66. doi: 10.1148/radiol.2451060530.
Wentz RJ, Manduca A, Fletcher JG, Siddiki HA, Shields RC, Vrtiska TJ, Spencer GC, Primak AN, Zhang J, Nielson TA, McCollough CH, Yu L. SPIE Medical Imaging 2007.: Physiology, Function, and Structure from Medical Images, 2007; 6511:1-9
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2A3360
Identifier Type: -
Identifier Source: secondary_id
FAMRI 2
Identifier Type: -
Identifier Source: secondary_id
1994-04
Identifier Type: -
Identifier Source: org_study_id